8-K2.029.01
FOR IMMEDIATE RELEASE
MDT to acquire platform ($570M)
EDGARMDT: FOR IMMEDIATE RELEASE
Medtronic PLC (MDT) just filed. MDT to acquire platform ($570M) (8-K 2026-09-01). Exhibit numbers: Diluted EPS $1.14; Deal $570M. Why it matters: FY27 organic revenue growth guidance 50 basis points to 7.25% to 7.75%, and FY27 diluted non-GAAP EPS guidance to the new ra Transaction value about $570M We continue to make targeted investments in innovation, portfolio development, and commercial execution that will support sustainable long-term value creatio…
Those exhibit numbers sit next to the income-statement cache: Latest reported MDT revenue for 2025-10-24 was $8.96B. Net income was $1.38B. Revenue was up 4.5% from 2025-07-25 to 2025-10-24. MDT currently screens at market cap $100.08B and trailing P/E 20.9. The MDT filings page is the source view; the stock page is the research view.
EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what Medtronic PLC said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.
8-KEX-99.12.029.01
FOR IMMEDIATE RELEASE
MDT to acquire platform ($570M)
- Diluted EPS
- $1.14
- Deal
- $570M
Why it matters
- FY27 organic revenue growth guidance 50 basis points to 7.25% to 7.75%, and FY27 diluted non-GAAP EPS guidance to the new ra
- Transaction value about $570M
- We continue to make targeted investments in innovation, portfolio development, and commercial execution that will support sustainable long-term value creatio…
0
10-K
0
10-Q
1
8-K
0
Form 4
Recent filings
EDGAR is the official archive. Browse all MDT filings.
Frequently asked questions
What did MDT just say?
MDT to acquire platform ($570M)
Where are MDT SEC filings?
1 cached filing is on this page. EDGAR remains the official archive (CIK 0001613103).
What is an 8-K Item 2.02?
Item 2.02 is the earnings exhibit. Lician reads EX-99.1 for revenue, growth, EPS, and guidance — not a form-type label.